Rare Disease Treatment Market Poised for Robust Growth Driven by Gene Therapies and Precision Medicine
• Global rare disease therapeutics market valued at $98.61 billion in 2022, forecasted to reach $176.83 billion by 2028 with 10.4% CAGR • Innovative gene therapies and precision medicine leading charge, bolstered by regulatory incentives and rising disease prevalence • Collaborations between industry and academia fueling advancements; technological innovations like CRISPR-Cas9 offer potential • Hematologic diseases propelling growth; injectables preferred route of administration for efficacy and quick effects • North America leads the market currently based on strong research, regulations, and healthcare infrastructure